C4A and metabolic dysfunction-associated steatotic liver disease: It has been reported that the fibroblast growth factor concentration is decreased in patients with NAFLD (39–41), which may have been responsible for the increase in C4 concentration; conversely, it has also been reported that the fibroblast growth factor concentration is not decreased in NAFLD (13, 42).